Cited by 221Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.

How Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?

Open access

Welty, Francine K.·2013·Current Cardiology Reports

DOI 10.1007/s11886-013-0400-4PMC PMC4465984

Open this paper in CoChat — free account

Abstract

This review article summarizes recent research into the mechanisms as to how elevated levels of triglyceride (TG) and low levels of high- density- lipoprotein cholesterol (HDL-C) contribute to inflammation and atherosclerosis. Evidence supports the role of TG-rich lipoproteins in signaling mechanisms via apolipoproteins C-III and free fatty acids leading to activation of NFKβ, VCAM-1 and other inflammatory mediators which lead to fatty streak formation and advanced atherosclerosis. Moreover, the cholesterol content in TG-rich lipoproteins has been shown to predict CAD risk better than LDL-C. In addition to reverse cholesterol transport, HDL has many other cardioprotective effects which include regulating immune function. The "functionality" of HDL appears more important than the level of HDL-C. Insulin resistance and central obesity underlie the pathophysiology of elevated TG and low HDL-C in metabolic syndrome and type 2 diabetes. Lifestyle recommendations including exercise and weight loss remain first line therapy in ameliorating insulin resistance and the adverse signaling processes from elevated levels of TG-rich lipoproteins and low HDL-C.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s11886-013-0400-4

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted
Kawakami, A., Osaka, M., Aikawa, M., Uematsu, S., Akira, S., Libby, P., Shimokado, K., Sacks, F. M., & Yoshida, M. (2008) · Circulation Research · doi:10.1161/circresaha.108.178426 · Cited by 76
Retracted
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 2×
“%) with MS*** 4.3 25 0.03 AIM- HIGH [109] Stopped early after 3 years due to lack of benefit N Niacin extended release 1.5-2 g vs placebo; all received simvastatin 40– 80 mg+Ezetimibe 10 mg if needed 3414 men and women with CAD Fatal CVD, nonfatal MI, ischemic stroke, hospitalization for acute coronary syndrome, coron…”
BackgroundInfluential
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · cited 6×
“In a subset analysis of the Action to Control Cardiovascular Risk in Diabetes (ACCORD), those with TG ≥2.3 mmol/L (204 mg/dL) (TG was lowered an average of 35”
BackgroundMethodInfluential
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Barter, P., Gotto, A. M., LaRosa, J. C., Maroni, J., Szarek, M., Grundy, S. M., Kastelein, J. J. P., Bittner, V., & Fruchart, J.-C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064278 · Cited by 1,610
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411 · cited 1×
“7 mmol/L (150 mg/dL) [102]; therefore, there is no need to measure LDL particle size.”
Background
Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease: The Bezafibrate Infarction Prevention (BIP) Study
(2000) · Circulation · doi:10.1161/01.cir.102.1.21 · Cited by 1,273
Natural regulatory T cells control the development of atherosclerosis in mice
Ait‐Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,126
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115
Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
Napoli, C., D'Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., & Palinski, W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119813 · Cited by 1,014
Exercise for overweight or obesity
Shaw, K. A., Gennat, H. C., O'Rourke, P., & Del Mar, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003817.pub3 · Cited by 950
Apolipoprotein B-48 Is the Product of a Messenger RNA with an Organ-Specific In-Frame Stop Codon
Chen, S. H., Habib, G. M., Yang, C., Gu, Z.-W., Lee, B. R., Weng, S. A., Silberman, S. R., Cai, S.-J., Deslypère, J. P., Rosseneu, M., et al. (1987) · Science · doi:10.1126/science.3659919 · Cited by 756
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Pollin, T. I., Damcott, C. M., Shen, H., Ott, S. H., Shelton, J., Horenstein, R. B., Post, W., McLenithan, J. C., Bielak, L. F., Peyser, P. A., et al. (2008) · Science · doi:10.1126/science.1161524 · Cited by 688
Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease
Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631
Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.
Kowal, R. C., Herz, J., Goldstein, J. L., Esser, V., & Brown, M. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5810 · Cited by 595
ACQUIRED IMMUNODEFICIENCY SYNDROME IN RWANDA
de Perre, P. V., Lepage, P., Kestelyn, P. G., Hekker, A. C., Rouvroy, D., Bogaerts, J., Kayihigi, J., Butzler, J., & Clumeck, N. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90240-x · Cited by 571
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome
Scott, R., O'Brien, R., Fulcher, G., Pardy, C., d'Emden, M., Tse, D., Taskinen, M.-R., Ehnholm, C., Keech, A., & on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators (2009) · Diabetes Care · doi:10.2337/dc08-1543 · Cited by 551
Importance of Different Pathways of Cellular Cholesterol Efflux
Yancey, P. G., Bortnick, A. E., Kellner-Weibel, G., de la Llera-Moya, M., Phillips, M. C., & Rothblat, G. H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000057572.97137.dd · Cited by 516
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
Podrez, E. A., Febbraio, M., Sheibani, N., Schmitt, D. C., Silverstein, R. L., Hajjar, D. P., Cohen, P. A., Frazier, W. A., Hoff, H. F., & Hazen, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8574 · Cited by 461
Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of Chylomicrons
Beigneux, A. P., Davies, B. S. J., Gin, P., Weinstein, M. M., Farber, E., Qiao, X., Peale, F., Bunting, S., Walzem, R. L., Wong, J. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.02.002 · Cited by 445
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X.-M., Dziura, J., Lifton, R. P., & Shulman, G. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907295 · Cited by 428
Recent progress in understanding apolipoprotein B.
Young, S. G. (1990) · Circulation · doi:10.1161/01.cir.82.5.1574 · Cited by 421
Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability
Nishi, K., Itabe, H., Uno, M., Kitazato, K. T., Horiguchi, H., Shinno, K., & Nagahiro, S. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000033829.14012.18 · Cited by 409
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Fisher, E. A. A., Feig, J. E., Hewing, B., Hazen, S. L., & Smith, J. D. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300133 · Cited by 404
Tissue–Specific Insulin Signaling, Metabolic Syndrome, and Cardiovascular Disease
Rask‐Madsen, C., & Kahn, C. R. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241919 · Cited by 390
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study
Koren, M. J., Scott, R. C., Kim, J. B., Knüsel, B., Liu, T., Lei, L., Bolognese, M. A., & Wasserman, S. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61771-1 · Cited by 366
A Proposal Linking Atherogenesis to the Interaction of Endothelial Lipoprotein Lipase with Triglyceride-Rich Lipoproteins
Zilversmit, D. B. (1973) · Circulation Research · doi:10.1161/01.res.33.6.633 · Cited by 338
Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor.
Nigon, F., Lesnik, P., Rouis, M., & Chapman, M. J. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41629-3 · Cited by 325
The Role of the Microsomal Triglygeride Transfer Protein in Abetalipoproteinemia
Varoqueaux, N., Aggerbeck, L. P., Bouma, M. E., & Wetterau, J. R. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.663 · Cited by 308
Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells
Kawakami, A., Aikawa, M., Alcaide, P., Luscinskas, F. W., Libby, P., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.106.622514 · Cited by 305
Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease
Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.22.2858 · Cited by 284
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Ooi, E. M. M., Barrett, P. H. R., Chan, D. C., & Watts, G. F. (2008) · Clinical Science · doi:10.1042/cs20070308 · Cited by 282
Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions
Han, S., Liang, C.-P., Seimon, T. A., Ranalletta, M., Welch, C. L., Collins-Fletcher, K., Accili, D., Tabas, I. A., & Tall, A. R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.008 · Cited by 278
Lipoprotein predictors of the severity of coronary artery disease in men and women.
Reardon, M. F., Nestel, P. J., Craig, I. H., & Harper, R. W. (1985) · Circulation · doi:10.1161/01.cir.71.5.881 · Cited by 266
Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.707 · Cited by 265
INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MEN
Krauss, R., Williams, P. T., Brensike, J. F., Detre, K. M., Lindgren, F. T., Kelsey, S. F., VRANIZAN, K. M., & Levy, R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92734-6 · Cited by 256
Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes.
Sparks, J. D., & Sparks, C. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38966-5 · Cited by 255
New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism
Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255 · cited 1×
“The metabolism of TG-rich containing lipoprotein fractions significantly impacts the levels and composition of other lipoprotein fractions which also contribute to cardiovascular risk [20].”
Background
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets
Lahoute, C., Herbin, O., Mallat, Z., & Tedgui, A. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.62 · Cited by 235
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men
Lamarche, B., Uffelman, K. D., Carpentier, A. C., Cohn, J. S., Steiner, G., Barrett, P. H. R., & Lewis, G. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5286 · Cited by 230
Triglycerides and Heart Disease
Goldberg, I. J., Eckel, R. H., & McPherson, R. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.226100 · Cited by 224
Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
Zheng, C., Khoo, C., Furtado, J., & Sacks, F. M. (2010) · Circulation · doi:10.1161/circulationaha.109.875807 · Cited by 223
Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells
Kawakami, A., Aikawa, M., Libby, P., Alcaide, P., Luscinskas, F. W., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.105.591743 · Cited by 206
Human apolipoprotein B-100 heparin-binding sites.
Weisgraber, K. H., & Rall, S. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60931-7 · Cited by 194
A PROPOSED GENETIC MARKER FOR CORONARY HEART DISEASE RISK
Austin, King, M., VRANIZAN, K. M., & Krauss, R. M. (1990) · Cited by 194
Sterol Regulatory Element-binding Protein Negatively Regulates Microsomal Triglyceride Transfer Protein Gene Transcription
Sato, R., Miyamoto, W., Inoue, J., Terada, T., Imanaka, T., & Maeda, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24714 · Cited by 193
Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
Hamsten, A., Walldius, G., Szamosi, A., Dahlén, G., & Fairé, U. D. (1986) · Circulation · doi:10.1161/01.cir.73.6.1097 · Cited by 192
Dynamic Changes in Regulatory T Cells Are Linked to Levels of Diet-Induced Hypercholesterolemia
Maganto-García, E., Tarrio, M. L., Grabie, N., Bu, D.-X., & Lichtman, A. H. (2011) · Circulation · doi:10.1161/circulationaha.110.006411 · Cited by 187
Association of Remnant Lipoprotein Levels With Impairment of Endothelium-Dependent Vasomotor Function in Human Coronary Arteries
Kugiyama, K., Doi, H., Motoyama, T., Soejima, H., Misumi, K., Kawano, H., Nakagawa, O., Yoshimura, M., Ogawa, H., Matsumura, T., et al. (1998) · Circulation · doi:10.1161/01.cir.97.25.2519 · Cited by 187
Very-Low-Density Lipoprotein Response Element in the Promoter Region of the Human Plasminogen Activator Inhibitor-1 Gene Implicated in the Impaired Fibrinolysis of Hypertriglyceridemia
Eriksson, P., Nilsson, L., Karpe, F., & Hamsten, A. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.1.20 · Cited by 187
Introduction:Structure and metabolism of plasma lipoproteins.
Havel, J. (1995) · Medical Entomology and Zoology · Cited by 178
Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)
Mack, W. J., Krauss, R. M., & Hodis, H. N. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.5.697 · Cited by 173
Update on strategies to increase HDL quantity and function
Duffy, D., & Rader, D. J. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.94 · Cited by 172
The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism
Ginsberg, H. N., & Fisher, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800090-jlr200 · Cited by 172
LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic Patients
Lee, S.-J., Campos, H., Moye, L. A., & Sacks, F. M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000066131.01313.eb · Cited by 170
Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans
Hurt‐Camejo, E., Olsson, U., Wiklund, O., Bondjers, G., & Camejo, G. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1011 · Cited by 165
The lipid raft hypothesis revisited – New insights on raft composition and function from super‐resolution fluorescence microscopy
Owen, D. M., Magenau, A., Williamson, D. J., & Gaus, K. (2012) · BioEssays · doi:10.1002/bies.201200044 · Cited by 162
Intermediate-Density Lipoproteins and Progression of Carotid Arterial Wall Intima-Media Thickness
Hodis, H. N., Mack, W. J., Dunn, M. E., Liu, C., Ci-hua, L., Selzer, R. H., & Krauss, R. M. (1997) · Circulation · doi:10.1161/01.cir.95.8.2022 · Cited by 155
Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr−/−, ApoA-I−/− Mice
Wilhelm, A. J., Zabalawi, M., Owen, J. S., Shah, D., Grayson, J. M., Major, A. S., Bhat, S., Gibbs, D. P., Thomas, M. J., & Sorci‐Thomas, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134130 · Cited by 145
Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.
Fager, G., Wiklund, O., Olofsson, S. ‐., Wilhelmsen, L., & Bondjers, G. (1981) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.1.4.273 · Cited by 139
Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction
Hamsten, A., Walldius, G., Dahlén, G., JOHANSSON, B., & DEFAIRE, U. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90051-1 · Cited by 138
Relationship between plasma lipid concentrations and coronary artery disease in 496 patients.
Gotto, A. M., Gorry, G. A., Thompson, J. R., Cole, J. S., Trost, R., Yeshurun, D., & DeBakey, M. E. (1977) · Circulation · doi:10.1161/01.cir.56.5.875 · Cited by 136
Apolipoprotein A-I and Its Role in Lymphocyte Cholesterol Homeostasis and Autoimmunity
Wilhelm, A. J., Zabalawi, M., Grayson, J. M., Weant, A. E., Major, A. S., Owen, J., Bharadwaj, M. S., Walzem, R. L., Chan, L., Oka, K., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183442 · Cited by 124
Chylomicron and chylomicron remnant catabolism
Mahley, R. W., & Hussain, M. M. (1991) · Current Opinion in Lipidology · doi:10.1097/00041433-199106000-00005 · Cited by 122
Triglyceride-rich lipoproteins and the progression of coronary artery disease
Hodis, H. N., & Mack, W. J. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199508000-00004 · Cited by 118
Human Apolipoprotein (Apo) B-48 and ApoB-100 Kinetics With Stable Isotopes
Welty, F. K., Lichtenstein, A. H., Barrett, P. H. R., Dolnikowski, G. G., & Schaefer, E. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.2966 · Cited by 117
Self-citation
High Density Lipoprotein Biogenesis, Cholesterol Efflux, and Immune Cell Function
Sorci‐Thomas, M. G., & Thomas, M. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300135 · Cited by 116
Differential effects of regulatory T cells on the initiation and regression of atherosclerosis
Foks, A. C., Frodermann, V., ter Borg, M., Habets, K. L. L., Bot, I., Zhao, Y., Eck, M. V., van Berkel, T. J. C., Kuiper, J., & van Puijvelde, G. H. M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.029 · Cited by 104
Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma
Mamo, J. C. L., Proctor, S. D., & Smith, D. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00220-2 · Cited by 98
Adaptive T cell immune responses and atherogenesis
Taleb, S., Tedgui, A., & Mallat, Z. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.02.003 · Cited by 92
In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish
Fang, L., Green, S. R., Baek, J. S., Lee, S., Ellett, F. E., Deer, E., Lieschke, G. J., Witztum, J. L., Tsimikas, S., & Miller, Y. I. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57755 · Cited by 92
A Docking Receptor for HDL Cholesterol Esters
Steinberg, D. H. (1996) · Science · doi:10.1126/science.271.5248.460 · Cited by 90
Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts
Cheng, A. M., Handa, P., Tateya, S., Schwartz, J., Tang, C., Mitra, P., Oram, J. F., Chait, A., & Kim, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033917 · Cited by 85
RISK FACTORS AND ANGIOGRAPHICALLY DETERMINED CORONARY OCCLUSION
Anderson, A. J., Barboriak, J. J., & Rimm, A. A. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112511 · Cited by 81
Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100
ABATEA, N., Vega, G., & Grundy, S. M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90187-y · Cited by 76
High-Density Lipoprotein and 4F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism
Navab, M., Reddy, S. T., Lenten, B. J. V., Buga, G. M., Hough, G., Wagner, A. C., & Fogelman, A. M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300282 · Cited by 72
Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.
Williams, K. J., Petrie, K. A., Brocia, R. W., & Swenson, T. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115434 · Cited by 70
The complexity of HDL
Francis, G. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.08.009 · Cited by 69
Plasma lipids as collateral risk factors in coronary artery disease—A study of 371 males with chest pain
Scott, D. W., Gotto, A. M., Cole, J. S., & Gorry, G. A. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90049-8 · Cited by 63
Apolipoprotein A-I Inhibits CD40 Proinflammatory Signaling via ATP-Binding Cassette Transporter A1-Mediated Modulation of Lipid Raft in Macrophages
Yin, K., Chen, W., Zhou, Z., Zhao, G., Lv, Y.-C., Ouyang, X.-P., Yu, X.-H., Fu, Y., Jiang, Z., & Tang, C. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12823 · Cited by 62
Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.
Sehayek, E., Lewin-Velvert, U., Chajek‐Shaul, T., & Eisenberg, S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115339 · Cited by 60
RELATION OF TRIGLYCERIDE LEVELS TO CORONARY ARTERY DISEASE: THE MILWAUKEE CARDIOVASCULAR DATA REGISTRY
Freedman, D. S., Gruchow, H. W., Anderson, A. J., Rimm, A. A., & Barboriak, J. J. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114906 · Cited by 59
Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans
Pavlic, M., Valéro, R., Duez, H., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.169383 · Cited by 53
Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease.
Fukushima, H., Kugiyama, K., Sugiyama, S., Honda, O., Koide, S., Nakamura, S., Kawano, H., Soejima, H., Miyamoto, S., Yoshimura, M., et al. (2001) · American Journal of Cardiology · doi:10.1016/s0002-9149(01)02115-4 · Cited by 48
Serum cholesterol and triglycerides in patients suffering from ischemic heart disease and in healthy subjects
Brunner, D., Altman, S., Loebl, K., Schwartz, S., & Levin, S. (1977) · Atherosclerosis · doi:10.1016/0021-9150(77)90157-5 · Cited by 48
Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels
Masuoka, H., Kamei, S., Wagayama, H., Ozaki, M., Kawasaki, A., Tanaka, T., Kitamura, M., Katoh, S., Shintani, U., Misaki, M., et al. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90240-0 · Cited by 40
CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice
Dong, L., Watanabe, K., Itoh, M. N., Huan, C.-R., Tong, X., Nakamura, T., Miki, M., Iwao, H. K., Nakajima, A., Sakai, T., et al. (2012) · International Immunology · doi:10.1093/intimm/dxs008 · Cited by 38
Hypertriglyceridemia: A Review Beyond Low-Density Lipoprotein
Rapp, R. J. (2002) · Cardiology in Review · doi:10.1097/00045415-200205000-00005 · Cited by 37
Relation of serum total cholesterol and triglyceride levels to the amount and extent of coronary arterial narrowing by atherosclerotic plaque in coronary heart disease
Cabin, H. S., & Roberts, W. C. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90183-8 · Cited by 36
The role of the cholesteryl ester transfer protein in lipoprotein metabolism
Swenson, T. L. (1991) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610070303 · Cited by 36
T Cell Costimulatory and Coinhibitory Pathways in Vascular Inflammatory Diseases
Lichtman, A. H. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00018 · Cited by 32
Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives
Kukita, H., Imamura, Y., Hamada, M., Joh, T., & Kokubu, T. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90122-8 · Cited by 31
The Complex Metabolic Mechanisms Relating Obesity to Hypertriglyceridemia
Eckel, R. H. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.233049 · Cited by 30
Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the activated factor X–prothrombin system
Tsuda, T., Yoshimura, H., & Hamasaki, N. (2006) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000240919.72930.ee · Cited by 27
Multiple risk prediction of myocardial infarction in women as compared with men.
Wilhelmsen, L., Bengtsson, C., Elmfeldt, D., VEDIN, A., Wilhelmsson, C., Tibblin, G., Lindqvist, O., & Wedel, H. (1977) · Heart · doi:10.1136/hrt.39.11.1179 · Cited by 26
Cholesterol Efflux and Metabolic Abnormalities Associated With Low High-Density-Lipoprotein-Cholesterol and High Triglycerides in Statin-Treated Coronary Men With Low-Density Lipoprotein-Cholesterol <70 mg/dl
Posadas‐Sánchez, R., Posadas‐Romero, C., Mendoza-Peŕez, E., Caracas-Portilla, N., Cardoso-Saldaña, G. C., Medina-Urrutia, A. X., Galarza, E. J., & Juárez-Rojas, J. G. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.017 · Cited by 24
Preventive Cardiology: A Companion to Braunwald's Heart Disease
Blumenthal, R. S., Foody, J. M., Wong, N. D., & D, E. B. M. (2011) · Medical Entomology and Zoology · Cited by 20
Relation of Triglyceride Levels to Coronary Artery Disease
Freedman, D. S., Gruchow, H. W., Anderson, A. J., Rimm, A., & Jj, B. (1988) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-198810000-00016 · Cited by 13
APOC3 Mutation, Serum Triglyceride Concentrations, and Coronary Heart Disease
Tsai, M. Y., & Ordovás, J. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.124669 · Cited by 11
T CELLS ARE ACTIVE PARTICIPANTS IN THE PROGRESSION OF ATHEROSCLEROTIC PLAQUES
Antohe, F. (2011) · Cited by 7
The Contribution of Triglycerides and Triglyceride-Rich Lipoproteins to Atherosclerotic Cardiovascular Disease
Welty, F. K. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00015-9 · Cited by 1
Self-citation

Sorted by citations

Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial
Athinarayanan, S. J., Adams, R. N., Hallberg, S. J., McKenzie, A. L., Bhanpuri, N. H., Campbell, W. W., Volek, J. S., Phinney, S. D., & McCarter, J. P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00348 · Cited by 324
The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
Kosmas, C. E., Polanco, S. R., Bousvarou, M. D., Papakonstantinou, E. J., Genao, E. P., Guzman, E., & Kostara, C. E. (2023) · Diagnostics · doi:10.3390/diagnostics13050929 · Cited by 327
Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease
Dedkova, E. N., & Blatter, L. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00260 · Cited by 227
Impact of food processing on the glycemic index (GI) of potato products
Nayak, B., Berrios, J. D. J., & Tang, J. (2013) · Food Research International · doi:10.1016/j.foodres.2013.12.020 · Cited by 175
Vascular inflammation and low‐density lipoproteins: is cholesterol the link? A lesson from the clinical trials
Catapano, A. L., Pirillo, A., & Norata, G. D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13805 · Cited by 138

See all 221

Authors: Welty, F. K.
Affiliations: Beth Israel Deaconess Medical Center (US)
Corresponding author: Welty, Francine K.
ORCID: Welty, Francine K.
Venue: Current Cardiology Reports
Publisher: Springer Science and Business Media LLC
Published: 2013-07-24
Volume: 15
Issue: 9
Pages: 400-400
ISSN: 1523-3782 (ISSN-L)
1534-3170
DOI: 10.1007/s11886-013-0400-4
PMC: PMC4465984
OpenAlex: W2020040555
Cited by: 221
References: 120
Citations by year: 2026: 16 · 2025: 23 · 2024: 26 · 2023: 34 · 2022: 21 · 2021: 23 · 2020: 16 · 2019: 19 · 2018: 15 · 2017: 12 · 2016: 7 · 2015: 3 · 2014: 4 · 2013: 2
FWCI: 0.94
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Current Cardiology Reports (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (5p50hl083813-05)
National Heart, Lung, and Blood Institute (P50-HL083813)
National Institute of Dental and Craniofacial Research (R01DE018184)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords: triglyceride elevation, low HDL cholesterol, atherosclerosis, atherothrombosis, inflammation, triglyceride-rich lipoproteins, apolipoprotein C-III, free fatty acids, NF-κB, VCAM-1, fatty streak formation, coronary artery disease risk, reverse cholesterol transport, HDL function, immune function, insulin resistance, abdominal obesity, metabolic syndrome, type 2 diabetes, physical activity, weight loss
MeSH terms: Coronary Artery Disease, Humans, Inflammation, Cholesterol, HDL, Thrombosis, Triglycerides, Biomarkers, Inflammation Mediators, Metabolic Syndrome, Atherosclerosis, Plaque, Atherosclerotic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks